Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.6.3 has been added, replacing v3.6.2, representing a minor backend/page update without affecting study content.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page's revision label changes from v3.6.0 to v3.6.2, signaling a newer edition of the page's metadata.SummaryDifference0.1%

- Check38 days agoChange DetectedRecruitment status changed to 'No longer looking for participants,' and new help sections such as 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study' were added. The page also updates the Intervention/Treatment heading formatting and the revision note to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

- Check45 days agoChange DetectedThe page revision stamp updated from v3.5.4 to v3.5.5, indicating a small backend update to the study record metadata. There is no indication that substantive study details were modified.SummaryDifference0.1%

- Check67 days agoChange DetectedAdds a new CABOSUN trial publication reference to Publications, including author names. The previous Cabozantinib vs Sunitinib citation and its erratum details are removed.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page footer “Revision” number was updated from v3.5.2 to v3.5.3, indicating a platform/version update without changing the underlying study information.SummaryDifference0.1%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.